Article 6G7RJ The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival

The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival

by
Emily Mullin
from Feed: All Latest on (#6G7RJ)
Story ImageEli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs.
External Content
Source RSS or Atom Feed
Feed Location http://feeds.wired.com/wired/index
Feed Title Feed: All Latest
Feed Link https://www.wired.com/
Feed Copyright © Condé Nast 2024
Reply 0 comments